ADCTakeover in ADC space: Abbvie snags ImmunoGenLatest NewsAbbVie buys ImmunoGen in US$10 billion deal, gains access to ADC for ovarian cancer. The ADC space gets hotter and hotter. Read more 30 November 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/adc_immunogen_folatalphaR-web.jpg 540 960 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-11-30 15:20:002024-07-09 12:57:34Takeover in ADC space: Abbvie snags ImmunoGen